Inventor · disambiguated record
Zhengxing Zhang
Also filed as: ZHANG ZHENGXING
8 granted patents·13 pending applications·5 citations·filing 2013–2025
76Inventor score
Files withPROVINCIAL HEALTH SERVICES AUTHORITY17WEICHAI POWER CO LTD2BRITISH COLUMBIA CANCER AGENCY BRANCH1UNIV BRITISH COLUMBIA1
Top patents by PatentIndex Score
21 records- 0193US11395857B2Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Granted Jul 26, 2022·3 cites·33 claims
- 0285US11504441B2Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Granted Nov 22, 2022·1 cites·20 claims
- 0378US2024350681A1Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 0476US12246076B2Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Granted Mar 11, 2025·0 cites·14 claims
- 0574US2024342321A1Novel cxcr4-targeting compoundsPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 0669US2023348535A1Radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 0768US11992537B2Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Granted May 28, 2024·0 cites·20 claims
- 0862US2024100203A1Novel cxcr4-targeting compoundsPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2021·Application pending·0 cites
- 0961US2025161501A1Radiolabeled Compounds for Imaging of Fibroblast Activation Protein (FAP) and Treatment of FAP-Related DisordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1060US10039846B2Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disordersBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2013·Granted Aug 7, 2018·1 cites·11 claims
- 1159US2023114807A1Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2022·Application pending·0 cites
- 1259US2025242064A1Cxcr4-targeting compounds, and methods of making and using the samePROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1357US2025195702A1Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2025·Application pending·0 cites
- 1452US2025186627A1Radiolabeled compounds targeting the prostate-specific membrane antigenPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2023·Application pending·0 cites
- 1551US2020339625A1Novel radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2018·Application pending·0 cites
- 1649US2022218852A1Novel radiolabelled cxcr4-targeting compounds for diagnosis and therapyPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2020·Application pending·0 cites
- 1747US12472272B2Radiolabelled compounds for diagnosis or treatment of prostate-specific membrane antigen- expressing cancerPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2020·Granted Nov 18, 2025·0 cites·40 claims
- 1845US2024018110A1Radiolabeled compounds targeting the prostate-specific membrane antigenUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 1943US11919399B2Hybrid power systemWEICHAI POWER CO LTD·Filed 2019·Granted Mar 5, 2024·0 cites·4 claims
- 2043US2021402016A1Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disordersPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2019·Application pending·0 cites
- 2138US12145568B2Control method and system for hybrid power systemWEICHAI POWER CO LTD·Filed 2019·Granted Nov 19, 2024·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →